Use of strong CYP1A2 inhibitors needs to be discontinued before initiating pirfenidone and averted in the course of therapy; if solid CYP1A2 inhibitors are the sole drug of option, dosage reductions are proposed Black, tarry stools blistering, peeling, or loosening in the skin upper body agony chills cough or hoarseness https://epz00477788876.blogsidea.com/35939925/pam3csk4-tfa-112208-00-1-free-base-things-to-know-before-you-buy